People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alessa Therapeutics, Inc. | — | Pharma | Series B | $31.6M | $129.6M | 2019 |
Pamela Munster at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Pamela Munster on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Lim | 1 | 14 |
| Douglas Crawford | 1 | 8 |
| Cam Gallagher | 1 | 7 |
| Peter Parker | 1 | 6 |
| Zachary Collins | 1 | 3 |
| Doug Crawford | 1 | 3 |
| John Maroney | 1 | 3 |
| Steve Tregay | 1 | 2 |
| Annie Mitsak | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.